Ron Martell, CEO, Director at Eloxx Pharmaceuticals, holds 0.00 shares in Eloxx Pharmaceuticals (Ticker: ELOX), holds ― shares in Plus Therapeutics (Ticker: PSTV), holds 331.19K shares in Jasper Therapeutics (Ticker: JSPR). Most recently, Ron Martell ― shares of Eloxx Pharmaceuticals on ― for an estimated value of ―.